The incidence of mammary gland tumors in dogs is a significant issue, characterized by notable rates of malignancy, recurrence, and disease burden. However, the lack of comprehensive information and correlated studies has presented challenges in establishing an effective surgical treatment strategy. In this study, a cohort of 95 dogs diagnosed with mammary tumors underwent evaluation using various surgical methods, medications, ovariohysterectomy, and assessments of margin completeness to analyze clinical outcomes. Significant clinical outcomes were observed following radical mastectomy and conservative surgeries, irrespective of TNM stages and histopathological grade of malignancy. Complete excision demonstrated significantly improved survival time and disease-free interval compared to incomplete excision. It is noted that complete surgical excision provides benefits, even in cases where lymphatic invasion is present. However, further investigations are necessary to validate the clinical results and mitigate side effects from radical mastectomy. Despite postoperative complications, several studies continue to advocate for more radical mastectomies due to their favorable risk-benefit ratio. Moreover, advanced inpatient treatments can now effectively manage or mitigate many of these complications. This study emphasizes the critical role of surgical proficiency and postoperative medication in treating malignant mammary tumors in dogs, and it provides insights that may contribute to the development of more effective treatment strategies for this condition.

Seung-Hyun Kim, Dae Sung Yoo, Dae-Hun Park, Seung-Sik Cho, Seungjo Park, Bock-Gie Jung, Sang-Ik Park, Chun-Sik Bae. J Vet Clin 2024;41:359-69. https://doi.org/10.17555/jvc.2024.41.6.359

Seung-Hyun Kim, Jun-Gyu Park, Seong-Soo Kang, Se-Eun Kim, Kwangsik Jang, Bock-Gie Jung, Sang-Ik Park, Chun-Sik Bae. Korean J. Vet. Serv. 2024;47:173-8. https://doi.org/10.7853/kjvs.2024.47.3.173

Concurrent occurrence of two independent primary malignancies in a single dog is rare and presents diagnostic and surgical challenges. A 9-year-old neutered male Cocker Spaniel was diagnosed with adrenal pheochromocytoma and splenic diffuse large B-cell lymphoma. Abdominal imaging revealed two distinct masses. Surgical management included adrenalectomy, splenectomy, mesenteric lymphadenectomy, and excision of a small mass adherent to the portal vein adventitia. Histopathology confirmed two separate malignancies, with chromogranin A positivity supporting pheochromocytoma and CD20 positivity confirming B-cell lymphoma. No additional metastatic lesions were identified, and the portal vein-associated mass was considered an isolated lesion closely adherent to the vessel wall, with its exact pathogenesis remaining uncertain. To the authors’ knowledge, this represents the first veterinary report describing adrenal pheochromocytoma with portal vein involvement successfully managed by surgical removal. The patient recovered well and remained disease-free for three years without adjuvant therapy. This case emphasizes that, even in technically demanding situations, meticulous surgical planning and comprehensive oncologic assessment can achieve durable remission and inform future approaches to complex veterinary cancers.

Effective pain control after orthopedic surgery is essential in veterinary practice, particularly in small-breed dogs with low physiological reserves. This study aimed to compare the analgesic efficacy and tolerability of five postoperative pain protocols across nine surgical procedures. A retrospective analysis was conducted in 205 small-breed dogs (≤7 kg) undergoing orthopedic surgeries. Dogs were assigned to one of five analgesic protocols: (A) carprofen, (B) tramadol–lidocaine–ketamine continuous-rate infusion, (C) butorphanol continuous-rate infusion, (D) hydromorphone continuous-rate infusion, and (E) multimodal analgesia combining local anesthetics, hydromorphone, and meloxicam. Pain was assessed at 6, 12, 24, 48, and 72 h using the Glasgow Composite Measure Pain Scale—Short Form. Analgesic efficacy was evaluated using pain trajectories, area-under-the-curve analysis, and pain resolution rates, and adverse effects were recorded. Dogs receiving multimodal analgesia achieved the most rapid and sustained pain relief, with all patients reaching pain resolution by 48 h. Hydromorphone alone showed comparable efficacy but was associated with more adverse effects, while tramadol–lidocaine–ketamine showed delayed pain relief and the highest rate of severe side effects. Multimodal analgesia provides superior pain control with acceptable safety in small-breed dogs undergoing orthopedic surgery, supporting its use based on surgical invasiveness and individual patient response.